Issue Open Date
|
16-Dec-21
|
Issue Closing Date
|
20-Dec-21
|
Application Money
|
100
|
Allotment Money
|
|
|
Price Band (Rs.)
|
265-274
|
Minimum Bid Quantity.
|
54
|
Issue Size (Shares)
|
25547445
|
Market Lot
|
1
|
|
|
Objective :
|
1. Funding capital expenditure requirements of our Company.2. Repayment and/ or pre-payment, in full or part, of certain borrowings availed by our Company.3. General corporate purposes.
|
|
|
|
Category
|
No. of Shares
|
No. of Shares
|
Subscription Ratio
|
|
Offered / Reserved
|
Bid For
|
|
Non-Institutional Investors
|
3962263
|
638780418
|
161.22
|
Qualified Institutional Buyers
|
7924527
|
252234270
|
31.83
|
Retail Individual Investors
|
7924527
|
252234270
|
31.83
|
|
|
|
Business Description
We are one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (“APIs”), with afocus on research and development. As of March 31, 2021, we have niche product offerings of 39 APIs focusedon diverse therapeutic segments such as an
|
|
Promoter's Holding
|
Total Share Capital
|
73168890
|
Offered to Public
|
14528299
|
Promoter's Holding (Pre-Issue)
|
99.98
|
Promoter's Holding (Post-Issue)
|
68.24
|
|
More..
|
|
|
|
|
Address
|
207/208 Udyog Bhavan Sonawala Road Goregaon (East)
Mumbai
,
Maharashtra
,
400063
Phone :
022-40332727
Email :
supriya@supriyalifescience.com
Website :
www.supriyalifescience.com
|
|
Registrar
|
Link Intime India Pvt Ltd.
C 101 247 Park LBS Marg Vikhroli (West) Mumbai
|
|
Listed at
|
BSE, NSE
|
|
Lead Manager
|
Axis Capital Ltd. ICICI Securities Ltd
|
|
Promoters
|
Satish Waman Wagh
|
|